Locksmith Bio is a biotechnology company that uses AI to map intrinsically disordered protein for novel drug discovery.
Locksmith Bio has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Locksmith Bio is headquartered in Dover, United States.
Locksmith Bio is a biotechnology company that uses AI to map intrinsically disordered protein for novel drug discovery.
Locksmith Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Locksmith Bio — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/locksmith-bio. Accessed October 4, 2026.
VCBacked. (2026). Locksmith Bio — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/locksmith-bio
{{cite web |title=Locksmith Bio — Funding & Investors |url=https://www.vcbacked.co/company/locksmith-bio |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated